Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects

NCT00864500 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Clobetasol Propionate 0.05% lotion, single exposure
DRUG: Clobex TM 0.05% Lotion, single exposure

Sponsor

Actavis Inc.